BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 15920323)

  • 1. Refractory ascites.
    Cárdenas A; Arroyo V
    Dig Dis; 2005; 23(1):30-8. PubMed ID: 15920323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Uriz J; Cárdenas A; Arroyo V
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ascites: diagnosis and management.
    Hou W; Sanyal AJ
    Med Clin North Am; 2009 Jul; 93(4):801-17, vii. PubMed ID: 19577115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of ascites in patients with end-stage liver disease.
    Saadeh S; Davis GL
    Rev Gastroenterol Disord; 2004; 4(4):175-85. PubMed ID: 15580152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis.
    Salerno F; Guevara M; Bernardi M; Moreau R; Wong F; Angeli P; Garcia-Tsao G; Lee SS
    Liver Int; 2010 Aug; 30(7):937-47. PubMed ID: 20492521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory ascites: definition, pathogenesis and treatment.
    Laffi G; La Villa G; Pinzani M; Foschi M; Carloni V; Casini Raggi V; Gentilini P
    Ann Ital Med Int; 1993; 8(1):38-46. PubMed ID: 8485009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ascites: pathogenesis and therapeutic principles.
    Møller S; Henriksen JH; Bendtsen F
    Scand J Gastroenterol; 2009; 44(8):902-11. PubMed ID: 19479632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of ascites in cirrhosis.
    Sandhu BS; Sanyal AJ
    Clin Liver Dis; 2005 Nov; 9(4):715-32, viii. PubMed ID: 16207572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cirrhotic ascites: pathogenesis and management.
    Garcia-Tsao G
    Gastroenterologist; 1995 Mar; 3(1):41-54. PubMed ID: 7743121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of cirrhotic ascites.
    Schouten J; Michielsen PP
    Acta Gastroenterol Belg; 2007; 70(2):217-22. PubMed ID: 17715638
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.
    Rössle M; Ochs A; Gülberg V; Siegerstetter V; Holl J; Deibert P; Olschewski M; Reiser M; Gerbes AL
    N Engl J Med; 2000 Jun; 342(23):1701-7. PubMed ID: 10841872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and treatment of fluid and electrolyte imbalance in cirrhosis.
    Cárdenas A; Ginès P
    Semin Nephrol; 2001 May; 21(3):308-16. PubMed ID: 11320500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.
    Moore KP; Wong F; Gines P; Bernardi M; Ochs A; Salerno F; Angeli P; Porayko M; Moreau R; Garcia-Tsao G; Jimenez W; Planas R; Arroyo V
    Hepatology; 2003 Jul; 38(1):258-66. PubMed ID: 12830009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid and electrolyte management of ascites in patients with cirrhosis.
    Bass M
    Crit Care Nurs Clin North Am; 1998 Dec; 10(4):459-67. PubMed ID: 10326425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis.
    Ginès P; Uriz J; Calahorra B; Garcia-Tsao G; Kamath PS; Del Arbol LR; Planas R; Bosch J; Arroyo V; Rodés J
    Gastroenterology; 2002 Dec; 123(6):1839-47. PubMed ID: 12454841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An update on the pathogenesis and clinical management of cirrhosis with refractory ascites.
    Neong SF; Adebayo D; Wong F
    Expert Rev Gastroenterol Hepatol; 2019 Apr; 13(4):293-305. PubMed ID: 30791777
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Transjugular intrahepatic portosystemic stent-shunts or paracentesis in the treatment of cirrhotic patients with refractory ascites].
    Ainsworth MA; Nielsen OH
    Ugeskr Laeger; 2005 Aug; 167(35):3273-6. PubMed ID: 16138966
    [No Abstract]   [Full Text] [Related]  

  • 19. Review article: Management of ascites and associated complications in patients with cirrhosis.
    Kuiper JJ; de Man RA; van Buuren HR
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():183-93. PubMed ID: 18081661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of ascites in cirrhosis. Diuretics, peritoneovenous shunt, and large-volume paracentesis.
    Arroyo V; Ginès P; Planas R
    Gastroenterol Clin North Am; 1992 Mar; 21(1):237-56. PubMed ID: 1568775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.